ClinicalTrials.gg
RecruitingNCT06808035Updated Sep 11, 2026

Understanding Perinatal Spinal Cord Injury

An interventional study of Activity-Based Recovery Training and Transcutaneous Spinal Cord Stimulation in Perinatal Spinal Cord Injury, sponsored by University of Louisville. Recruiting at 1 site in United States. Open to participants aged 3 Years to 8 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by University of Louisville · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Jan 2024, registered Dec 2024).
  • Started Jan 2024; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
6
Allocation
Not applicable
Ages
3 Years to 8 Years
Sex
All
01

Study summary

The purpose of this study is to deepen our understanding of children who have a cervical spinal cord injury obtained in utero or at birth and examine the effects of tailored activity-based recovery training (ABRT) in combination with transcutaneous spinal cord stimulation (scTS). This is a within subjects, pre-post design study. Neurophysiological, sensorimotor, and autonomic assessments will occur pre, interim, and post 40 sessions of ABRT in conjunction with scTs.

Read the detailed description

Infants who suffer perinatal spinal cord injuries (SCI) are injured during a critical period of neurological development. Confounded further by on-going development, they are particularly vulnerable to the consequences of SCI (e.g., paralysis and paresis, hypertonia, bladder/bowel dysfunction, respiratory compromise) on lifelong health, function, and quality of life. There are only 4 published case reports of the presentation and rehabilitation of perinatally injured children. Clinically, children with high cervical SCI compared to those with low level SCI exhibit slow and limited active upper and lower extremity (UE, LE) movements, high tone, and poor trunk control. Children with low cervical lesions have a more typical pattern of loss below the injury level. We intend to expand our understanding of the scope of perinatal SCI and its impact in order to address integrated, whole-body system rehabilitation.

The overall objective of this study is to deepen our understanding of pediatric perinatal cervical SCIs and then formulate tailored treatment strategies that encourage neuroplasticity, enhance functional capacity, and improve the overall quality of life of children. The results from this study will provide pilot data and evidence that we can comprehensively assess and develop a therapeutic roadmap to improve whole-body function in children with perinatal SCI.

This is a pilot, within subjects, repeated measures, pre-post design.

Aim 1: Investigate the impact of perinatal, cervical SCI comparing high (C2-3) and low (C4-6) injuries on a whole-body profile of health: neurophysiological, sensorimotor, autonomic.

Aim 2: In children with perinatal SCIs, investigate the effect of 40 sessions of tailored transcutaneous spinal stimulation (scTS) paired with activity-based restorative therapies (ABRTs) on neurophysiological profile (spinal pathway functional integrity) and sensorimotor function.

Aim 3: In children with chronic, cervical, perinatal SCIs, investigate the effect of 40 sessions of scTS paired with ABRT on autonomic functions, i.e., respiratory, blood pressure regulation, bladder/bowel.

02

Conditions studied

  • Perinatal Spinal Cord Injury

Keywords

  • Spinal Cord Injury
  • Activity-Based Recovery Training
  • Perinatal-Onset
  • Transcutaneous Spinal Cord Stimulation
  • Whole-Systems
  • Pediatric Spinal Cord Injury
03

In context

Spinal Cord Injuries

2,025 studies on the registry are indexed under Spinal Cord Injuries; 537 are open to participants now.

This study's planned enrollment of 6 is below the median of 24 across 1,633 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of Louisville is the lead sponsor of 291 studies on the registry; 54 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 7 (37%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosed with a perinatal (injured in utero or at birth), upper motor neuron spinal cord injury involving cervical spinal levels
  • discharged from inpatient hospitalization/inpatient rehabilitation

Exclusion criteria

Exclusion Criteria:

  • Botox use within the past 3 months
  • Current oral baclofen or baclofen pump use
  • Musculoskeletal impairment limiting range of motion (e.g. severe scoliosis), unhealed fracture, or other medical impairment limiting study participation
  • History of allodynia (heightened skin sensitivity typically at the level of the lesion site)
  • History of scoliosis surgery
  • Ventilator-dependence
  • Unwillingness to wean from daytime use of thoroco/lumbosacral orthosis and ankle/foot orthosis during the intervention period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
6 participants (estimated)

Study arms

  • Experimental
    Cervical Perinatal SCI

    Participants with high cervical and low cervical SCI will perform tailored ABRT+scTS. Pre, interim, and post assessments of neurophysiological, sensorimotor, and autonomic function will be compared within-subjects and between high and low cervical SCI groups. Participants will come for daily activity-based recovery training (ABRT) + transcutaneous spinal stimulation (scTS). ABRT+scTS will take place 5 days per week for approximately 2.5 hours each (1.5 hours of lower extremity training and 1 hour of upper extremity training) for a total of 40 sessions consisting of facilitated sitting, standing, stepping, and UE motor tasks such as grasping, reaching, and hand manipulations.

    Other: Activity-Based Recovery Training · Device: Transcutaneous Spinal Cord Stimulation

Interventions

  • OtherActivity-Based Recovery Training

    ABRT uses task-specific training to improve neuromuscular capacity. ABRT will be tailored to participant presentation. Activity-Based Locomotor Training consists of stepping, standing, and sitting activities on a body weight support (BWS) treadmill using a harness and while overground. Therapists and trainers provide hands-on assistance for safety and kinematics. BWS is varied during sessions with a goal of optimal kinematics at the lowest BWS. Activities performed standing will focus on alignment incorporating static, active, and dynamic tasks. Activities performed during overground are based on neuromuscular capacity and appropriate developmental and functional levels. Principles of ABRT will be shared with parents/caregivers to foster activity in the home and community. Activity-Based Upper Extremity Training uses task-specific training of the trunk and upper extremities administered in sitting or standing via manual facilitation or support in a stander for best posture.

    Also known as: Activity-Based Training, Activity-Based Locomotor Training, Activity-Based Upper Extremity Training, ABRT, ABT, AB-LT, AB-UET

  • DeviceTranscutaneous Spinal Cord Stimulation

    Transcutaneous Spinal Cord Stimulation (scTs) is a non-invasive stimulation administered over the skin using a modulated biphasic or monophasic waveform at 15-90Hz and a carrier frequency of 5-10kHz. Bouts of scTs at the cervical, thoracic, lumbar, and/or coccygeal level will be administered midline or just lateral to the spinous processes during activity-based recovery training.

    Also known as: scTS, TcStim

06

What researchers measure

Primary outcomes

  1. Participant Specific Outcome Measures

    Participant specific outcomes measures will be identified at study initiation via parent interview. Parents will identify daily, functional tasks that the participant has difficulty or challenges performing at a practical, successful level. Functional tasks performed by the participant will be video recorded at study initiation, post-20 sessions, and post-40 intervention sessions. Metrics of task performance include success or failure of the task.

    Time frame: At study enrollment, following 20 sessions (approximately 1 month), and following 40 sessions (approximately 2 months)

Secondary outcomes

  1. Supine Functional Neurophysiological Assessment (FNPA)

    1\) Averaged electromyography (EMG) root mean square (RMS) values above and below the level of the lesion. 2) EMG isolated to limb performing the task and proximal stabilizers (yes, no). If no, identify location (limbs/trunk) of auxiliary EMG activity, 3) Timing of response

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  2. Acoustic Startle Response (ASR)

    Percent of responses above (blink) and below the level of the lesion.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  3. Somatosensory Evoked Potentials (SSEP)

    1. Presence of response in the brain from stimulation of tibial and median nerves in the periphery, below and above the spinal cord lesion. 2. If response is present, latency of responses (mseconds) from initiation of stimulation and across the lesion.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  4. Stand/Step Functional Neurophysiological Assessment (FNPA)

    Test completed in children who are non-ambulatory. 1\) Can child initiate a step in the treadmill environment with body weight support? From parallel stance: Yes or No. From stride stance: Yes or No. if yes, hip range of motion (degrees) during swing.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  5. Upper Extremity Motor Control Assessment

    Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) scores, Box and Block Test (BBT( number of blocks), transer BBT time (tBBT), hand grip force, pinch force

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  6. Trunk Motor Control Assessment

    Averaged electromyography RMS values of the trunk muscles, trunk posture (angles)

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  7. Segmental Assessment of Trunk Control

    Score between 1-20 indicating the level of appropriate static, active, and reactive control of the trunk and level of support described.

    Time frame: At study enrollment, following 20 sessions (approximately 1 month), and following 40 sessions (approximately 2 months)

  8. Pediatric Neuromuscular Recovery Scale (NRS)

    Overall and individual task NRS scores. Units of 1A-4C

    Time frame: At study enrollment, following 20 sessions (approximately 1 month), and following 40 sessions (approximately 2 months)

  9. Spasticity of upper extremity and lower extremity

    Number of cycles elicited in response to the pendulum drop-test

    Time frame: At study enrollment, following 20 sessions (approximately 1 month), and following 40 sessions (approximately 2 months)

  10. Respiratory Motor Control Assessment (RMCA)

    Lung volume, maximum inspiratory pressure, maximum expiratory pressure, and peak cough flow will be reported.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  11. Bowel Questionnaire

    Total Neurogenic Bowel Dysfunction (NBD) score and interpretation of impairment: 0-6 Very Minor, 7-9 Minor, 10-13 Moderate, 14+ Severe neurogenic bowel dysfunction.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  12. Overground Walking Assessment of Gait

    1. Observational Gait Scale (OGS) Tool - score out of 22 2. Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI) Category Scores

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  13. Bladder Questionnaire

    A change in lower urinary tract function within the study timeframe per variable from an impaired state to recovery will be reported, specifically: Awareness of need to empty the bladder, bladder emptying methods, average number of voluntary bladder emptying, involuntary urine leakage, a change in medication, surgical procedures.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

  14. Gross Motor Function Measure-88 (GMFM-88)

    88 tasks across 5 dimensions: 1. lying/rolling, 2) sitting, 3) crawling/kneeling, 4) standing, 5) walking/running/jumping. Individual item scores (0-3, not tested (NT), dimension percentage, and overall percentage will be reported.

    Time frame: At study enrollment and following 40 sessions (approximately 2 months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Related links

Individual participant data

Plan to share: Yes — IPD of demographics and primary and secondary outcomes measures will be shared via Open Data Commons for Spinal Cord Injury.

Time frame: IPD will be made available beginning 1 year after publication with no end date.

Access criteria: Authorized users who have acquired an OCD account will have access to IPD.

Data sharing details ↗ · odc-sci.org

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jan 2027, 36 months after the start.

Of 790 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 36 months is close to that.

Counting every sponsor, half of 839 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2024
First posted
Feb 5, 2025
StartActual
Jan 9, 2024
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2027
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06808035
Collaborators
Vanderbilt University, University of Leeds, Kentucky Spinal Cord and Head Injury Research Board
Responsible party
Andrea L. Behrman, PhD, PT (Professor, University of Louisville) — Principal investigator
First posted
Feb 5, 2025
Start date
Jan 9, 2024
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Sep 11, 2026

Study contacts

Lisa R. Clayton, CCRP
Contact
kidskickparalysis@louisville.edu
502-569-7996

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion